Forma Therapeutics Holdings, Inc. FMTX
20.01 0.00 (+0.00%)
At closeOct 13, 2022, 4:00 PM EDT
19.98 Day range 20.01
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 21.00 +4.9% upside
Now 20.01
- Target (low)
- 20.00
- Target (mean)
- 21.00
- Target (high)
- 23.00
Ratings (-1m) 6 1 buy · 5 hold · 0 sell
- Strong buy1
- Buy0
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 6
- 2 months ago 6
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.10 | -1.12 – -1.08 | -0.91 | -20.9% | 670.00K | 0.0% | 3 |
| Next quarter | -1.13 | -1.17 – -1.10 | -1.06 | -6.6% | 0 | 0.0% | 3 |
| Current year | -4.26 | -4.31 – -4.21 | -3.65 | -16.7% | 670.00K | 0.0% | 3 |
| Next year | -3.60 | -3.80 – -3.41 | -4.26 | +15.5% | 9.40M | +1303.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 2022 | Credit Suisse | Downgrade | Outperform | Neutral |
| Sep 2, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Sep 2, 2022 | Oppenheimer | Downgrade | Outperform | Perform |
| Sep 2, 2022 | Jefferies | Downgrade | Buy | Hold |
| May 27, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 12, 2021 | SVB Leerink | Maintained | — | Outperform |
| Aug 17, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 2, 2021 | Craig-Hallum | Initiated | — | Buy |
| Jun 11, 2021 | SVB Leerink | Maintained | — | Outperform |
| Mar 31, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 8, 2020 | Credit Suisse | Maintained | — | Outperform |
| Dec 8, 2020 | SVB Leerink | Maintained | — | Outperform |
| Nov 19, 2020 | Cantor Fitzgerald | Initiated | — | Overweight |
| Sep 8, 2020 | HC Wainwright & Co. | Initiated | — | Buy |